CABA logo

Cabaletta Bio (CABA) Company Overview

Profile

Full Name:

Cabaletta Bio, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 25, 2019

Indexes:

Not included

Description:

Cabaletta Bio (CABA) is a biotechnology company focused on developing innovative cell therapies for autoimmune diseases. They use advanced technology to create treatments that target specific immune cells, aiming to improve patient outcomes and reduce side effects. Their goal is to transform how autoimmune conditions are treated.

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 18, 25 HC Wainwright & Co.
Buy
Jan 17, 25 HC Wainwright & Co.
Buy
Dec 20, 24 Evercore ISI Group
In-Line
Dec 19, 24 Wells Fargo
Equal-Weight
Nov 18, 24 HC Wainwright & Co.
Buy
Nov 15, 24 Wells Fargo
Overweight
Nov 15, 24 HC Wainwright & Co.
Buy
Oct 10, 24 UBS
Buy
Sep 17, 24 HC Wainwright & Co.
Buy
Aug 12, 24 Wells Fargo
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Cabaletta Bio?
  • Does Cabaletta Bio pay dividends?
  • What sector is Cabaletta Bio in?
  • What industry is Cabaletta Bio in?
  • What country is Cabaletta Bio based in?
  • When did Cabaletta Bio go public?
  • Is Cabaletta Bio in the S&P 500?
  • Is Cabaletta Bio in the NASDAQ 100?
  • Is Cabaletta Bio in the Dow Jones?
  • When was Cabaletta Bio's last earnings report?
  • When does Cabaletta Bio report earnings?
  • Should I buy Cabaletta Bio stock now?

What is the ticker symbol for Cabaletta Bio?

The ticker symbol for Cabaletta Bio is NASDAQ:CABA

Does Cabaletta Bio pay dividends?

No, Cabaletta Bio does not pay dividends

What sector is Cabaletta Bio in?

Cabaletta Bio is in the Healthcare sector

What industry is Cabaletta Bio in?

Cabaletta Bio is in the Biotechnology industry

What country is Cabaletta Bio based in?

Cabaletta Bio is headquartered in United States

When did Cabaletta Bio go public?

Cabaletta Bio's initial public offering (IPO) was on October 25, 2019

Is Cabaletta Bio in the S&P 500?

No, Cabaletta Bio is not included in the S&P 500 index

Is Cabaletta Bio in the NASDAQ 100?

No, Cabaletta Bio is not included in the NASDAQ 100 index

Is Cabaletta Bio in the Dow Jones?

No, Cabaletta Bio is not included in the Dow Jones index

When was Cabaletta Bio's last earnings report?

Cabaletta Bio's most recent earnings report was on Nov 14, 2024

When does Cabaletta Bio report earnings?

The next expected earnings date for Cabaletta Bio is Mar 21, 2025

Should I buy Cabaletta Bio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions